美国 · SEC FORM 4
Tectonic Therapeutic, Inc.
TECX · Nasdaq · CIK 0001681087 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
5 sales · 9 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-11 · REICIN ALISE.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,222,184
- 上期报告
- 2,218,549
- 日均成交量
- 275,508
- 回补天数
- 8.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-11 | REICIN ALISE | 买入 (P) | Common Stock | 2,500 | USD 21.10 | USD 52,750 | SEC 申报 ↗ |
| 2026-02-11 | REICIN ALISE | 买入 (P) | Common Stock | 2,500 | USD 21.10 | USD 52,750 | SEC 申报 ↗ |
| 2026-02-10 | Lochner Daniel | 买入 (P) | Common Stock | 6,000 | USD 21.61 | USD 129,660 | SEC 申报 ↗ |
| 2025-04-11 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 63,184 | USD 16.31 | USD 1,030,531 | SEC 申报 ↗ |
| 2025-04-10 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 53,950 | USD 16.73 | USD 902,584 | SEC 申报 ↗ |
| 2025-04-09 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 24,789 | USD 14.76 | USD 365,900 | SEC 申报 ↗ |
| 2025-04-07 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 500,000 | USD 17.10 | USD 8,550,000 | SEC 申报 ↗ |
| 2025-02-05 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 789,294 | USD 50.68 | USD 39,999,977 | SEC 申报 ↗ |
| 2025-02-05 | Lochner Daniel | 买入 (P) | Common Stock | 4,617 | USD 54.14 | USD 249,964 | SEC 申报 ↗ |
| 2024-10-22 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 300,000 | USD 33.59 | USD 10,077,000 | SEC 申报 ↗ |
| 2024-09-26 | SPRINGER TIMOTHY A | 买入 (P) | Common Stock | 50,000 | USD 28.82 | USD 1,440,829 | SEC 申报 ↗ |
| 2024-05-14 | Leonard Braden Michael | 买入 (P) | Common Stock | 296,882 | USD 1.30 | USD 385,947 | SEC 申报 ↗ |
| 2024-05-13 | Leonard Braden Michael | 买入 (P) | Common Stock | 469,753 | USD 1.25 | USD 586,815 | SEC 申报 ↗ |
| 2021-07-07 | Vickers Philip J. | 买入 (P) | Common Stock | 4,800 | USD 8.35 | USD 40,080 | SEC 申报 ↗ |
| 2021-02-17 | Donenberg Phillip B. | 买入 (P) | Common Stock | 2,000 | USD 11.71 | USD 23,420 | SEC 申报 ↗ |
Form 4 申报证据
38 transaction lines in the latest 365-day window; 115 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | McNamara Peter | 卖出 (S) | Common Stock | 536 | USD 23.04 | USD 12,349 | SEC 申报 ↗ |
| 2026-09-25 | Schwabish Marc | 代扣税 (F) | Common Stock | 411 | USD 23.67 | USD 9,728 | SEC 申报 ↗ |
| 2026-09-25 | Ruddy Marcella K. | 代扣税 (F) | Common Stock | 525 | USD 23.67 | USD 12,427 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | McNamara Peter | 卖出 (S) | Common Stock | 536 | USD 23.04 | USD 12,349 | SEC 申报 ↗ |
| 2026-09-25 | Schwabish Marc | 代扣税 (F) | Common Stock | 411 | USD 23.67 | USD 9,728 | SEC 申报 ↗ |
| 2026-09-25 | Ruddy Marcella K. | 代扣税 (F) | Common Stock | 525 | USD 23.67 | USD 12,427 | SEC 申报 ↗ |
| 2026-09-25 | REICIN ALISE | 代扣税 (F) | Common Stock | 1,545 | USD 23.67 | USD 36,570 | SEC 申报 ↗ |
| 2026-09-25 | McNamara Peter | 代扣税 (F) | Common Stock | 444 | USD 23.67 | USD 10,509 | SEC 申报 ↗ |
| 2026-09-25 | Lochner Daniel | 代扣税 (F) | Common Stock | 520 | USD 23.67 | USD 12,308 | SEC 申报 ↗ |
| 2026-08-25 | McNamara Peter | 卖出 (S) | Common Stock | 43 | USD 36.52 | USD 1,570 | SEC 申报 ↗ |
| 2026-08-25 | McNamara Peter | 期权行权／转换 (M) | Common Stock | 43 | USD 14.71 | USD 633 | SEC 申报 ↗ |
| 2026-08-12 | McNamara Peter | 卖出 (S) | Common Stock | 43 | USD 35.00 | USD 1,505 | SEC 申报 ↗ |
| 2026-08-12 | McNamara Peter | 期权行权／转换 (M) | Common Stock | 43 | USD 14.71 | USD 633 | SEC 申报 ↗ |
| 2026-06-30 | McNamara Peter | 卖出 (S) | Common Stock | 172 | USD 35.00 | USD 6,020 | SEC 申报 ↗ |
| 2026-06-30 | McNamara Peter | 期权行权／转换 (M) | Common Stock | 172 | USD 14.71 | USD 2,530 | SEC 申报 ↗ |
| 2026-06-20 | REICIN ALISE | 代扣税 (F) | Common Stock | 924 | USD 30.34 | USD 28,034 | SEC 申报 ↗ |
| 2026-05-04 | Ruddy Marcella K. | 卖出 (S) | Common Stock | 1,065 | USD 30.00 | USD 31,950 | SEC 申报 ↗ |
| 2026-04-01 | Ruddy Marcella K. | 卖出 (S) | Common Stock | 1,000 | USD 31.05 | USD 31,050 | SEC 申报 ↗ |
| 2026-03-06 | Ruddy Marcella K. | 卖出 (S) | Common Stock | 10,000 | USD 30.00 | USD 300,000 | SEC 申报 ↗ |
| 2026-03-06 | McNamara Peter | 卖出 (S) | Common Stock | 6,262 | USD 30.17 | USD 188,935 | SEC 申报 ↗ |
| 2026-03-06 | McNamara Peter | 期权行权／转换 (M) | Common Stock | 2,715 | USD 3.36 | USD 9,113 | SEC 申报 ↗ |
| 2026-03-04 | Schwabish Marc | 奖励／授予 (A) | Common Stock | 19,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-04 | Ruddy Marcella K. | 奖励／授予 (A) | Common Stock | 26,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-04 | REICIN ALISE | 奖励／授予 (A) | Common Stock | 76,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-04 | McNamara Peter | 卖出 (S) | Common Stock | 1,650 | USD 25.00 | USD 41,250 | SEC 申报 ↗ |
| 2026-03-04 | McNamara Peter | 奖励／授予 (A) | Common Stock | 23,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-04 | Lochner Daniel | 奖励／授予 (A) | Common Stock | 26,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | McNamara Peter | 卖出 (S) | Common Stock | 1,649 | USD 22.06 | USD 36,377 | SEC 申报 ↗ |
| 2026-02-11 | REICIN ALISE | 买入 (P) | Common Stock | 2,500 | USD 21.10 | USD 52,750 | SEC 申报 ↗ |
| 2026-02-11 | REICIN ALISE | 买入 (P) | Common Stock | 2,500 | USD 21.10 | USD 52,750 | SEC 申报 ↗ |
| 2026-02-10 | Schwabish Marc | 期权行权／转换 (M) | Common Stock | 4,500 | USD 2.38 | USD 10,710 | SEC 申报 ↗ |
| 2026-02-10 | Lochner Daniel | 买入 (P) | Common Stock | 6,000 | USD 21.61 | USD 129,660 | SEC 申报 ↗ |
| 2026-02-04 | Schwabish Marc | 代扣税 (F) | Common Stock | 1,619 | USD 23.22 | USD 37,593 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | TECX |
| CIK | 0001681087 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 115 transaction lines from 2020-01-28 to 2026-09-30 26 P purchase lines · 17 S sale lines · 72 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.